S

Sport Lisboa e Benfica Futebol SAD
ELI:SLBEN

Watchlist Manager
Sport Lisboa e Benfica Futebol SAD
ELI:SLBEN
Watchlist
Price: 6.42 EUR -0.62%
Market Cap: 147.7m EUR

Intrinsic Value

The intrinsic value of one SLBEN stock under the Base Case scenario is 5.51 EUR. Compared to the current market price of 6.42 EUR, Sport Lisboa e Benfica Futebol SAD is Overvalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SLBEN Intrinsic Value
5.51 EUR
Overvaluation 14%
Intrinsic Value
Price
S
Base Case Scenario

Valuation History
Sport Lisboa e Benfica Futebol SAD

What is Valuation History?
Ask AI Assistant
What other research platforms think about SLBEN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SLBEN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sport Lisboa e Benfica Futebol SAD.

Explain Valuation
Compare SLBEN to

Fundamental Analysis

Sport Lisboa e Benfica Futebol SAD
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SLBEN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sport Lisboa e Benfica Futebol SAD

Current Assets 90.6m
Cash & Short-Term Investments 920k
Receivables 62.1m
Other Current Assets 27.6m
Non-Current Assets 482.8m
PP&E 95.9m
Intangibles 186.1m
Other Non-Current Assets 200.9m
Current Liabilities 214.1m
Accrued Liabilities 1.2m
Short-Term Debt 30m
Other Current Liabilities 182.9m
Non-Current Liabilities 228.1m
Long-Term Debt 122.2m
Other Non-Current Liabilities 105.9m
Efficiency

Free Cash Flow Analysis
Sport Lisboa e Benfica Futebol SAD

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sport Lisboa e Benfica Futebol SAD

Revenue
179m EUR
Cost of Revenue
-86.5m EUR
Gross Profit
92.6m EUR
Operating Expenses
-103.6m EUR
Operating Income
-11.1m EUR
Other Expenses
-20.3m EUR
Net Income
-31.4m EUR
Fundamental Scores

SLBEN Profitability Score
Profitability Due Diligence

Sport Lisboa e Benfica Futebol SAD's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
ROIC is Increasing
34/100
Profitability
Score

Sport Lisboa e Benfica Futebol SAD's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

SLBEN Solvency Score
Solvency Due Diligence

Sport Lisboa e Benfica Futebol SAD's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Short-Term Solvency
Positive Net Debt
30/100
Solvency
Score

Sport Lisboa e Benfica Futebol SAD's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SLBEN Price Targets Summary
Sport Lisboa e Benfica Futebol SAD

There are no price targets for SLBEN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Sport Lisboa e Benfica Futebol SAD
does not pay dividends
Shareholder Yield

Current shareholder yield for SLBEN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one SLBEN stock?

The intrinsic value of one SLBEN stock under the Base Case scenario is 5.51 EUR.

Is SLBEN stock undervalued or overvalued?

Compared to the current market price of 6.42 EUR, Sport Lisboa e Benfica Futebol SAD is Overvalued by 14%.

Back to Top